Susceptibility to flavivirus-specific antiviral response of Oas1b affects the neurovirulence of the Far-Eastern subtype of tick-borne encephalitis virus

Archives of Virology

Volumn 158, Issue 5, 2013, Pages 1039-1046

  Yoshii, Kentaro ^a   Moritoh, Kanako ^a   Nagata, Noriyo ^b   Yokozawa, Kana ^a   Sakai, Mizuki ^a   Sasaki, Nobuya ^a   Kariwa, Hiroaki ^a   Agui, Takashi ^a   Takashima, Ikuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVIVIRUS; MUS; TICK-BORNE ENCEPHALITIS VIRUS;

EID: 84876713551     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1579-1     Document Type: Article

References (32)

1. Barkhash AV, Perelygin AA, Babenko VN, Myasnikova NG, Pilipenko PI, Romaschenko AG, Voevoda MI, Brinton MA (2010) Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease. J Infect Dis 202: 1813-1818.
2. Chebath J, Benech P, Hovanessian A, Galabru J, Revel M (1987) Four different forms of interferon-induced 2', 5'-oligo(A) synthetase identified by immunoblotting in human cells. J Biol Chem 262: 3852-3857.
3. Chiba N, Iwasaki T, Mizutani T, Kariwa H, Kurata T, Takashima I (1999) Pathogenicity of tick-borne encephalitis virus isolated in Hokkaido, Japan in mouse model. Vaccine 17: 779-787.
4. Chumakov MP, Levkovich EN (1985) Russian spring summer encephalitis. The international catalog of arboviruses including certain other viruses of vertebrates. http://wwwn. cdc. gov/arbocat/catalog-listing. asp?VirusID=404&SI=1.
5. Ecker M, Allison SL, Meixner T, Heinz FX (1999) Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 80(Pt 1): 179-185.
6. Elbahesh H, Jha BK, Silverman RH, Scherbik SV, Brinton MA (2011) The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells. Virology 409: 262-270.
7. Goto A, Hayasaka D, Yoshii K, Mizutani T, Kariwa H, Takashima I (2002) Genetic and biological comparison of tick-borne encephalitis viruses from Hokkaido and far-eastern Russia. Jpn J Vet Res 49: 297-307.
8. Hartmann R, Olsen HS, Widder S, Jorgensen R, Justesen J (1998) p59OASL, a 2'-5' oligoadenylate synthetase like protein: a novel human gene related to the 2'-5' oligoadenylate synthetase family. Nucleic Acids Res 26: 4121-4128.
9. Hayasaka D, Ivanov L, Leonova GN, Goto A, Yoshii K, Mizutani T, Kariwa H, Takashima I (2001) Distribution and characterization of tick-borne encephalitis viruses from Siberia and far-eastern Asia. J Gen Virol 82: 1319-1328.
10. Hayasaka D, Nagata N, Fujii Y, Hasegawa H, Sata T, Suzuki R, Gould EA, Takashima I, Koike S (2009) Mortality following peripheral infection with tick-borne encephalitis virus results from a combination of central nervous system pathology, systemic inflammatory and stress responses. Virology 390: 139-150.
11. Hovanessian AG, Laurent AG, Chebath J, Galabru J, Robert N, Svab J (1987) Identification of 69-kd and 100-kd forms of 2-5A synthetase in interferon-treated human cells by specific monoclonal antibodies. EMBO J 6: 1273-1280.
12. Kakuta S, Shibata S, Iwakura Y (2002) Genomic structure of the mouse 2', 5'-oligoadenylate synthetase gene family. J Interferon Cytokine Res: Off J Int Soc Interferon Cytokine Res 22: 981-993.
13. Kovalev SY, Mukhacheva TA, Kokorev VS, Belyaeva IV (2012) Tick-borne encephalitis virus: reference strain Sofjin and problem of its authenticity. Virus Genes 44(2): 217-224.
14. Leonova GN, Pavlenko EV, Krylova NV, Belikov SI, Kondratov IG (2011) Characterization of the strains of tick-borne encephalitis virus of the far-eastern subtype isolated from patients with different forms of infection. International Union of Microbiological Societies 2011 Congress, Sapporo.
15. Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, Johnson B, Johnson H, Pape J, Foster GA, Krysztof D, Follmann D, Stramer SL, Margolis LB, Murphy PM (2009) Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog 5: e1000321.
16. Mashimo T, Lucas M, Simon-Chazottes D, Frenkiel MP, Montagutelli X, Ceccaldi PE, Deubel V, Guenet JL, Despres P (2002) A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci USA 99: 11311-11316.
17. Mertens E, Kajaste-Rudnitski A, Torres S, Funk A, Frenkiel MP, Iteman I, Khromykh AA, Despres P (2010) Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2', 5'-oligoadenylate synthetase 1b. Virology 399: 176-185.
18. Moritoh K, Yamauchi H, Asano A, Yoshii K, Kariwa H, Takashima I, Isoda N, Sakoda Y, Kida H, Sasaki N, Agui T (2009) Generation of congenic mouse strains by introducing the virus-resistant genes, Mx1 and Oas1b, of feral mouse-derived inbred strain MSM/Ms into the common strain C57BL/6J. Jpn J Vet Res 57: 89-99.
19. Nagata N, Iwata N, Hasegawa H, Fukushi S, Yokoyama M, Harashima A, Sato Y, Saijo M, Morikawa S, Sata T (2007) Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J Virol 81: 1848-1857.
20. Perelygin AA, Scherbik SV, Zhulin IB, Stockman BM, Li Y, Brinton MA (2002) Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci USA 99: 9322-9327.
21. Pulit-Penaloza JA, Scherbik SV, Brinton MA (2012) Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation. Virology 425: 71-81.
22. Rebouillat D, Hovanessian AG (1999) The human 2', 5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J Interferon Cytokine Res: Off J Int Soc Interferon Cytokine Res 19: 295-308.
23. Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14: 778-809 Table of contents.
24. Sarkar SN, Ghosh A, Wang HW, Sung SS, Sen GC (1999) The nature of the catalytic domain of 2'-5'-oligoadenylate synthetases. J Biol Chem 274: 25535-25542.
25. Scherbik SV, Paranjape JM, Stockman BM, Silverman RH, Brinton MA (2006) RNase L plays a role in the antiviral response to West Nile virus. J Virol 80: 2987-2999.
26. Scherbik SV, Kluetzman K, Perelygin AA, Brinton MA (2007) Knock-in of the Oas1b(r) allele into a flavivirus-induced disease susceptible mouse generates the resistant phenotype. Virology 368: 232-237.
27. Silvia OJ, Pantelic L, Mackenzie JS, Shellam GR, Papadimitriou J, Urosevic N (2004) Virus spread, tissue inflammation and antiviral response in brains of flavivirus susceptible and resistant mice acutely infected with Murray Valley encephalitis virus. Arch Virol 149: 447-464.
28. Suss J (2011) Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview. Ticks Tick-Borne Dis 2: 2-15.
29. Takano A, Yoshii K, Omori-Urabe Y, Yokozawa K, Kariwa H, Takashima I (2011) Construction of a replicon and an infectious cDNA clone of the Sofjin strain of the Far-Eastern subtype of tick-borne encephalitis virus. Arch Virol 156: 1931-1941.
30. Takashima I, Morita K, Chiba M, Hayasaka D, Sato T, Takezawa C, Igarashi A, Kariwa H, Yoshimatsu K, Arikawa J, Hashimoto N (1997) A case of tick-borne encephalitis in Japan and isolation of the virus. J Clin Microbiol 35: 1943-1947.
31. Yoshii K, Konno A, Goto A, Nio J, Obara M, Ueki T, Hayasaka D, Mizutani T, Kariwa H, Takashima I (2004) Single point mutation in tick-borne encephalitis virus prM protein induces a reduction of virus particle secretion. J Gen Virol 85: 3049-3058.
32. Yoshii K, Mottate K, Omori-Urabe Y, Chiba Y, Seto T, Sanada T, Maeda J, Obara M, Ando S, Ito N, Sugiyama M, Sato H, Fukushima H, Kariwa H, Takashima I (2011) Epizootiological study of tick-borne encephalitis virus infection in Japan. J Vet Med Sci/Jpn Soc Vet Sci 73: 409-412.